Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02902835 · ClinicalTrials.gov registry record · NA

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3

A NA study, sponsored by Montefiore Medical Center.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT02902835 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02902835, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The goal of this study is to test whether peer mentors (i.e., individuals with past opioid addiction and prior incarceration) can facilitate entrance into buprenorphine (Suboxone) treatment for individuals with opioid use disorder who were recently released from jail or prison. In order to test whether it is helpful to have peer mentors paired with recently released individuals, the investigators will conduct an 18 month study, recruiting 72 formerly incarcerated individuals and assigning them by chance selection (like flipping a coin) to either a group that will receive peer mentorship or a group that will receive a referral to a community clinic.

Interventions

  • BEHAVIORAL BUP_FAST
  • BEHAVIORAL Referral to treatment

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2016-09-01
Est. Completion 2018-06-30
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02902835

The ClinicalTrials.gov registry entry for NCT02902835 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BUP_FAST is the first listed.

NCT02902835 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02902835 about?

NCT02902835 is a clinical study titled "BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3". The goal of this study is to test whether peer mentors (i.e., individuals with past opioid addiction and prior incarceration) can facilitate entrance into buprenorphine (Suboxone) treatment for individuals with opioid use disorder who were recently released from jail or prison. In order to test whet...

What is the current status of trial NCT02902835?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2016-09-01. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT02902835?

The interventions under investigation include: BUP_FAST (BEHAVIORAL), Referral to treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02902835?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.